Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Locations section now lists Maryland as a study site. The Maryland Locations entry and the HHS Vulnerability Disclosure link were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T00:34:19.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to study content, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:35:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 appears in the page's revision label. No changes to study details, eligibility criteria, or layout are visible; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T10:53:46.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page no longer displays the government funding notice about potential delays and operating status; core study details and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:06:36.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected for this page. The study details and related information appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T00:47:28.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T06:28:19.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.